Vittoria Biotherapeutics
About:
Vittoria Biotherapeutics is a gene-edited cell therapeutics company.
Website: https://vittoriabio.com
Top Investors: University of Pennsylvania, BioAdvance, SV Health Investors, Agent Capital, NYBC Ventures
Description:
Vittoria Biotherapeutics develops gene-edited cell therapies. they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.
Total Funding Amount:
$25M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Philadelphia, Pennsylvania, United States
Founded Date:
2021-01-01
Founders:
Marco Ruella
Number of Employees:
1-10
Last Funding Date:
2023-11-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai